BIOVERATIV Clinical Trials Recruiting 2018

The CAD STUDIES ARE NOW RECRUITING ADULTS ages 18 and older with primary cold agglutinin disease (CAD). The purpose of the CAD Studies is to determine the safety and effectiveness of an investigational medication for primary CAD. Individuals will be evaluated to determine their eligibility to participate. The investigational medication, study-related medical exams, and study-related laboratory tests will be provided to participants at no cost.

A special website has been created to provide more information about the CAD Studies. This site includes information on what to expect if you are enrolled and provides a list of participating research sites. Talk to your doctor and visit to learn more.

19 March, 2018

Apellis Clinical Trial Recruiting             2018

We have learned about a clinical research trial for a new investigational treatment option for subjects with primary Warm Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD).

Apellis Pharmaceuticals is sponsoring this trial to evaluate the effectiveness, safety and tolerability of an investigational medication for participants with wAIHA or CAD [NCT03226678].

For more information on this clinical trial and to enter your contact information for follow-up, please visit the trial website:

You may also contact Apellis directly at Click here to send an email or Betty Usdan at Click here to send an email

6th July, 2018


Print Friendly, PDF & Email